Aditxt, Inc. (NASDAQ:ADTX) Short Interest Update

Aditxt, Inc. (NASDAQ:ADTX) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 910,800 shares, a growth of 102.2% from the October 15th total of 450,400 shares. Based on an average trading volume of 2,420,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 10.4% of the shares of the company are sold short.

Insider Transactions at Aditxt

In related news, major shareholder Financial Lp Hrt sold 25,534 shares of Aditxt stock in a transaction dated Wednesday, October 16th. The stock was sold at an average price of $1.17, for a total value of $29,874.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.72% of the stock is owned by corporate insiders.

Aditxt Stock Performance

Aditxt stock opened at $0.37 on Wednesday. The firm has a 50 day simple moving average of $6.82 and a 200 day simple moving average of $43.66. Aditxt has a 1-year low of $0.35 and a 1-year high of $380.00.

Aditxt (NASDAQ:ADTX) last posted its quarterly earnings results on Monday, August 19th. The company reported ($167.60) EPS for the quarter. The firm had revenue of $0.04 million during the quarter.

Aditxt Company Profile

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.